These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Double-blind evaluation of deanol in tardive dyskinesia.
    Author: Penovich P, Morgan JP, Kerzner B, Karch F, Goldblatt D.
    Journal: JAMA; 1978 May 12; 239(19):1997-8. PubMed ID: 347112.
    Abstract:
    We administered deanol acetamidobenzoate, 2.0 g/day for four weeks, a double-blind, placebo-controlled crossover trial, to 14 patients with tardive dyskineasia. The patient population included both inpatients and outpatients. The response was evaluated by subjective clinical impression and scoring of filmed sequences. Patients' conditions improved significantly from baseline scores while receiving both deanol and placebo, but there was no distinction between the two treatments.
    [Abstract] [Full Text] [Related] [New Search]